483
Teva API India Ltd- MalanpurTeva API India Ltd- Malanpur – FDA 483, Apr 16, 2019
Record Details
An FDA inspection of Teva API India Pvt. Ltd. revealed significant deficiencies across its operations. The firm failed to conduct adequate risk assessments for impurities in Key Starting Materials and lacked properly validated cleaning processes for non-dedicated equipment. Additionally, the Quality Unit did not consistently follow its own procedures, and production equipment was stored in conditions that risked contamination.
View Company Profile
ID · b780b5fc-9af0-4f8a-9029-cc007329ef25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.